Trademark Attorney / Law Firm
Karin Segall, Andrew Baum, Paul Fields, Amy J. Benjamin, Eric A. Prager and Abigail Rubinstein – Trademark Portfolio
Karin Segall, Andrew Baum, Paul Fields, Amy J. Benjamin, Eric A. Prager and Abigail Rubinstein specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 1 of 1 total filing concentrated in this category. Currently, 0 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Karin Segall, Andrew Baum, Paul Fields, Amy J. Benjamin, Eric A. Prager and Abigail Rubinstein's trademark practice covers 1 Nice Classification class, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademark applications has Karin Segall, Andrew Baum, Paul Fields, Amy J. Benjamin, Eric A. Prager and Abigail Rubinstein filed?
Karin Segall, Andrew Baum, Paul Fields, Amy J. Benjamin, Eric A. Prager and Abigail Rubinstein has filed 1 trademark application with the United States Patent and Trademark Office (USPTO).
What trademark classes does Karin Segall, Andrew Baum, Paul Fields, Amy J. Benjamin, Eric A. Prager and Abigail Rubinstein specialize in?
Karin Segall, Andrew Baum, Paul Fields, Amy J. Benjamin, Eric A. Prager and Abigail Rubinstein has filed trademarks across 1 Nice Classification class. The most common practice areas include Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is Karin Segall, Andrew Baum, Paul Fields, Amy J. Benjamin, Eric A. Prager and Abigail Rubinstein's trademark registration success rate?
Karin Segall, Andrew Baum, Paul Fields, Amy J. Benjamin, Eric A. Prager and Abigail Rubinstein has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.